Literature DB >> 20463635

Donor pancreata: evolving approaches to organ allocation for whole pancreas versus islet transplantation.

Thierry Berney1, Paul R V Johnson.   

Abstract

As islet transplantation increasingly enters the clinical arena, its coexistence with vascularized pancreas transplantation makes it necessary to reassess the questions of donor selection and allocation. In answering these questions, one must put in the balance the short-term morbidity of pancreas transplantation with the long-term attrition of islet grafts. The preferential allocation of pancreases from obese and older donors for islet isolation has been based on their association with worse pancreas transplant outcomes and better islet isolation results in islet yields. In this overview, we show that transplanted islet mass does not necessarily correlate with graft function and make the case that donor selection criteria for islet transplantation, and hence allocation rules, may need to be redefined.

Entities:  

Mesh:

Year:  2010        PMID: 20463635     DOI: 10.1097/TP.0b013e3181e25a40

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

Review 2.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Authors:  A M James Shapiro
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 3.  Pancreas transplantation: solid organ and islet.

Authors:  Shruti Mittal; Paul Johnson; Peter Friend
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

4.  Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist.

Authors:  Barbara Ludwig; Avi Rotem; Janine Schmid; Gordon C Weir; Clark K Colton; Mathias D Brendel; Tova Neufeld; Norman L Block; Karina Yavriyants; Anja Steffen; Stefan Ludwig; Triantafyllos Chavakis; Andreas Reichel; Dimitri Azarov; Baruch Zimermann; Shiri Maimon; Mariya Balyura; Tania Rozenshtein; Noa Shabtay; Pnina Vardi; Konstantin Bloch; Paul de Vos; Andrew V Schally; Stefan R Bornstein; Uriel Barkai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

5.  Deceased organ donor factors influencing pancreatic graft transplantation and survival.

Authors:  Mitchell B Sally; Margaret Katherine Ellis; Michael Hutchens; Tahnee Groat; Elizabeth Swanson; Madhukar S Patel; Claus U Niemann; Darren J Malinoski
Journal:  Clin Transplant       Date:  2019-06       Impact factor: 2.863

6.  Transplantation of human islets without immunosuppression.

Authors:  Barbara Ludwig; Andreas Reichel; Anja Steffen; Baruch Zimerman; Andrew V Schally; Norman L Block; Clark K Colton; Stefan Ludwig; Stephan Kersting; Ezio Bonifacio; Michele Solimena; Zohar Gendler; Avi Rotem; Uriel Barkai; Stefan R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

7.  Pancreatic beta cell/islet mass and body mass index.

Authors:  Michael P Dybala; Scott K Olehnik; Jonas L Fowler; Karolina Golab; J Michael Millis; Justyna Golebiewska; Piotr Bachul; Piotr Witkowski; Manami Hara
Journal:  Islets       Date:  2019-01-22       Impact factor: 2.694

8.  Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis?

Authors:  Feng-Cheng Chou; Shing-Hwa Huang; Huey-Kang Sytwu
Journal:  Int J Endocrinol       Date:  2012-05-29       Impact factor: 3.257

9.  The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.

Authors:  Afaf Sahraoui; Maria Sörhede Winzell; Tracy Gorman; Dave M Smith; Stanko Skrtic; Merete Hoeyem; Shadab Abadpour; Lars Johansson; Olle Korsgren; Aksel Foss; Hanne Scholz
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 10.  Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges.

Authors:  Anthony Bruni; Boris Gala-Lopez; Andrew R Pepper; Nasser S Abualhassan; Am James Shapiro
Journal:  Diabetes Metab Syndr Obes       Date:  2014-06-23       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.